Literature DB >> 7974574

Costs of stroke in Sweden. A national perspective.

A Terént1, L A Marké, K Asplund, B Norrving, E Jonsson, P O Wester.   

Abstract

BACKGROUND AND
PURPOSE: Cost-effectiveness analyses of stroke management are hampered by paucity of economic data. We made an update of the direct and indirect costs of stroke in Sweden (population, 8.5 million).
METHODS: Direct costs (ie, the costs for hospital and outpatient care and social services) were estimated on the basis of two prospective population-based studies of stroke and of two nationwide cross-sectional inventories of bed-days and diagnoses. Indirect costs (ie, the costs for loss of productivity and early retirement) were based on official statistics.
RESULTS: The direct annual costs of care for stroke patients in 1991 equaled 7836 million Swedish krona (SKr) ($1306 million in US dollars), and the indirect costs, 2430 million SKr ($405 million). The cost of stroke care was 1208 SKr ($201) per inhabitant in Sweden. The expected direct costs per patient from first stroke to death were 440,000 SKr ($73,333). When prestroke costs for other diseases and advanced age were subtracted, the sum was reduced to 180,000 SKr ($30,000).
CONCLUSIONS: Costs for hospital and outpatient care and social services accounted for 76% of Swedish stroke costs and for 24% of costs for loss of production and early retirement. Only 41% of direct costs were stroke-related.

Entities:  

Mesh:

Year:  1994        PMID: 7974574     DOI: 10.1161/01.str.25.12.2363

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

Review 1.  A literature review of indirect costs associated with stroke.

Authors:  Heesoo Joo; Mary G George; Jing Fang; Guijing Wang
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-06-21       Impact factor: 2.136

2.  The cost of angina pectoris in Sweden.

Authors:  F Andersson; B Kartman
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

3.  Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole.

Authors:  M Chambers; J Hutton; J Gladman
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

4.  Cost of post-stroke outpatient care in Malaysia.

Authors:  Seyed Majid Akhavan Hejazi; Mazlina Mazlan; Saini Jeffery Freddy Abdullah; Julia Patrick Engkasan
Journal:  Singapore Med J       Date:  2015-02       Impact factor: 1.858

Review 5.  Long term cost-of-illness in stroke: an international review.

Authors:  Krista A Payne; Krista F Huybrechts; J Jaime Caro; Traci J Craig Green; Wendy S Klittich
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

6.  Changing face of stroke: implications for occupational therapy practice.

Authors:  Timothy J Wolf; Carolyn Baum; Lisa Tabor Conner
Journal:  Am J Occup Ther       Date:  2009 Sep-Oct

7.  [Long-term disease-related costs 4 years after stroke or TIA in Germany].

Authors:  Y Winter; C Wolfram; O Schöffski; R C Dodel; T Back
Journal:  Nervenarzt       Date:  2008-08       Impact factor: 1.214

8.  Young stroke mortality in fiji islands: an economic analysis of national human capital resource loss.

Authors:  Jagdish C Maharaj; Mahendra Reddy
Journal:  ISRN Neurol       Date:  2012-06-21

9.  The cost of first-ever stroke in Valle d'Aosta, Italy: linking clinical registries and administrative data.

Authors:  Edo Bottacchi; Giovanni Corso; Piera Tosi; Massimo Veronese Morosini; Giuseppe De Filippis; Laura Santoni; Gianluca Furneri; Cristina Negrini
Journal:  BMC Health Serv Res       Date:  2012-10-30       Impact factor: 2.655

10.  Process skill rather than motor skill seems to be a predictor of costs for rehabilitation after a stroke in working age; a longitudinal study with a 1 year follow up post discharge.

Authors:  Ann Björkdahl; Katharina Stibrant Sunnerhagen
Journal:  BMC Health Serv Res       Date:  2007-12-21       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.